Oral Edaravone (Treeway)

N/A

Report date: 2025/03/07 20:00:40

Base Information

Drug NameOral Edaravone (Treeway)
Drug Alias NameFAB-122TW-101FNP-122TW-001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFree radicals scavengersantioxidant
TargetsFree radicals
Therapy Area/IndicationsAmyotrophic Lateral SclerosisAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumSwedenPoland +[12
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesTreeway BV
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsAmyotrophic Lateral SclerosisAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A